Skip to main content
SpringerLink
Log in

Cardiovascular events with second-line antidiabetic medication

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. O'Brien MJ, et al. Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes. JAMA Network Open 1: e186125, No. 8, 21 Dec 2018. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2018.6125

  2. Callahan A, et al. A Second Opinion From Observational Data on Second-line Diabetes Drugs JAMA Network Open 1: e186119, No. 8, 21 Dec 2018. Available from: URL: http://dx.doi.org/10.1001/jamanetworkopen.2018.6119

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cardiovascular events with second-line antidiabetic medication. Reactions Weekly 1735, 8 (2019). https://doi.org/10.1007/s40278-019-56624-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-56624-1

Search

Navigation